跳至主要内容
临床试验/NCT04724759
NCT04724759已完成2 期

The Effect of Opioid-Free Anesthesia in TMJ Surgery: A Prospective Study

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年6月18日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Pain Score

研究概览

简要总结

This study aims is to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing oral and maxillofacial surgery (OMF) temporomandibular joint (TMJ) surgery.

详细描述

This study will enroll 60 patients undergoing TMJ surgery at Massachusetts General Hospital. Anesthetic care will be standardized according to current institutional standards of care. Intraoperative clinicians will not be blinded to group assignment. Patients will be randomized to one of two groups:

  • Group 1 - Opioid-free Anesthesia Patients: Patients who are not receiving opioids but the total intravenous anesthetic during surgery.
  • Group 2 - Standard Anesthesia Patients: Patients who undergo the standard of care and receive opioids as part of their anesthetic regimen.

Both groups employ strategies that are routinely used as part of standard clinical practice for TMJ surgery. Patients will otherwise receive the institutional standards of care for their surgical procedure and perioperative care.

Following intraoperative drug administration patients will be followed until discharge from the PACU to assess study endpoints while in the hospital. At the time of discharge from the PACU, members of the study team will ask the patient to compete a brief survey on their satisfaction with pain management.

Patients in this study will be anticipated to be discharged the same day as the surgical procedure. At the time of hospital or PACU discharge, the patient will be provided with a Medication Diary. This will be used to record pain medication administration in the first 48 hours after surgery, as well as any pain or complication they might experience at home.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 to 75 (inclusive)
  • Scheduled for TMJ surgery (including both unilateral and bilateral procedures)
  • Planned arthroscopic surgical procedure
  • Preoperative plan to discharge the same day

排除标准

  • Inability to provide written informed consent
  • Pregnant patients
  • Open TMJ Surgeries
  • Planned overnight admission
  • Mental status disorder or patient who are unable to communicate

研究组 & 干预措施

Opioid-free Anesthesia

Experimental

Patients in this arm will not receiving opioids but the total intravenous anesthetic during surgery. Patients in this group will receive an infusion of lidocaine, ketamine, or dexmedetomidine supplemented with other intravenous analgesics and intravenous and inhaled anesthetics.

干预措施: Dexmedetomidine / Ketamine / Lidocaine (Drug)

结局指标

主要结局

Pain Score

时间窗: Through in-hospital study completion, an average of 1 day

Pain will be measured using the eleven point (0 to 10) numeric rating scale with higher values representing a worse outcome. Pain scores will be recorded every 15 minutes until discharge from the post-anesthesia care unit (PACU) and at 12 and 24 hours postoperatively. Clinically documented pain scores will be recorded. Our primary outcome will be the worst documented pain score while in the PACU. Additional pain score time points will be evaluated as secondary endpoints.

次要结局

  • Perioperative Opioid Use(48 hours postoperatively)
  • Rescue Analgesia in the PACU(Through in-hospital study completion, an average of 1 day)
  • Pain Satisfaction(Completed upon the patient reaching PACU Phase I in the hospital, up to approximately 6 hours)
  • Incidence of Opioid Related Adverse Effects(48 hours postoperatively)
  • Length of Stay (PACU Discharge)(Through in-hospital study completion, an average of 1 day)
  • Percocet Use(48 hours postoperatively)
  • Length of Stay (Hospital Discharge)(Through in-hospital study completion, an average of 1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jingping Wang, MD, Ph.D.

Associate Professor

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验